Uncovering Overlooked Aspects of Axon Enterprise (AXON)

Shares of Industrials sector company Axon Enterprise moved -6.4% today, and are now trading at a price of $562.37. The Large-Cap stock's daily volume was 372,076 compared to its average volume of 878,364. The S&P 500 index returned a 1.0% performance.

Axon Enterprise, Inc. develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. The company is based in Scottsdale and has 3,330 full time employees. Its market capitalization is $42,883,411,968.

14 analysts are following Axon Enterprise and have set target prices ranging from $385.0 to $800.0 per share. On average, they have given the company a rating of buy. At today's prices, AXON is trading -3.85% away from its average analyst target price of $584.87 per share.

Over the last year, AXON's share price has increased by 138.9%, which represents a difference of 114.1% when compared to the S&P 500. The stock's 52 week high is $698.67 per share whereas its 52 week low is $244.01. With average free cash flows of $75.35 Million that have been growing at an average rate of 20.4% over the last 5 years, Axon Enterprise is in a position to continue its strong stock performance trend.

Date Reported Cash Flow from Operations ($ k) Capital expenditures ($ k) Free Cash Flow ($ k) YoY Growth (%)
2023 189,263 59,635 129,628 -27.81
2022 235,361 55,802 179,559 140.67
2021 124,494 49,886 74,608 318.48
2020 38,481 72,629 -34,148 -168.66
2019 65,673 15,939 49,734 -5.69
2018 63,875 11,139 52,736
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS